Canadian Online Pharmacy

CDER New June 08, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 7, 2012


New and Generic Drug Approvals

June 6, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Aggrastat tirofiban hydrochloride Injectable; Injection Medicure Labeling Revision
Aggrastat tirofiban hydrochloride Injectable; Injection Medicure Labeling Revision
Horizant gabapentin enacarbil Tablet, Extended Release; Oral Glaxo Grp Ltd Efficacy Supplement with Clinical Data to Support
Prinivil lisinopril Tablet; Oral Merck Labeling Revision
Prinzide hydrochlorothiazide; lisinopril Tablet; Oral Merck Labeling Revision
Ropinirole Hydrochloride ropinirole hydrochloride Tablet, Extended Release; Oral Watson Labs Inc Approval
Ropinirole Hydrochloride ropinirole hydrochloride Tablet, Extended Release; Oral Sandoz Inc Approval
Ropinirole Hydrochloride ropinirole hydrochloride Tablet, Extended Release; Oral Dr Reddys Labs Ltd Approval
Tridione trimethadione Capsule; Oral Abbott Labeling Revision
Tridione trimethadione Solution; Oral Abbott Labeling Revision
Tridione trimethadione Tablet; Oral Abbott Labeling Revision
Zithromax azithromycin For Suspension; Oral Pfizer Labeling Revision
Zithromax azithromycin For Suspension; Oral Pfizer Labeling Revision
Zithromax azithromycin Tablet; Oral Pfizer Labeling Revision
Zithromax azithromycin Tablet; Oral Pfizer Labeling Revision
Zithromax azithromycin Injectable; Injection Pfizer Labeling Revision
Zithromax azithromycin Tablet; Oral Pfizer Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery